Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001601485-26-000030
Filing Date
2026-03-12
Accepted
2026-03-12 16:39:52
Documents
17
Effectiveness Date
2026-03-12

Document Format Files

Seq Description Document Type Size
1 S-8 elicios-8march2026.htm S-8 95066
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 29730
3 EX-5.1 elicio-sx8opinionmarch20.htm EX-5.1 5104
4 EX-23.1 elicio-sx8auditorconsent.htm EX-23.1 1350
5 GRAPHIC elicio-sx8auditorconsent001.jpg GRAPHIC 75043
6 GRAPHIC elicio-sx8opinionmarch20001.jpg GRAPHIC 232743
7 GRAPHIC elicio-sx8opinionmarch20002.jpg GRAPHIC 103616
  Complete submission text file 0001601485-26-000030.txt   833239

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 10259
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294253 | Film No.: 26748471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)